Dr. James C. Yao on Everolimus in Pancreatic Neuroendocrine Tumors
13 Vues
• 07/13/23
0
0
Intégrer
administrator
Les abonnés
James C. Yao, MD, discusses the administration of everolimus (Afinitor) for patients with pancreatic neuroendocrine tumors
For more resources and information regarding targeted therapies in cancer: http://targetedhc.com/
Montre plus
Commentaires de Facebook
SORT BY-
Meilleures Commentaires
-
Derniers Commentaires